ID18079A - Komposisi farmasi yang mengandung bahan pemercepat osteogenesis - Google Patents

Komposisi farmasi yang mengandung bahan pemercepat osteogenesis

Info

Publication number
ID18079A
ID18079A IDP972959A ID972959A ID18079A ID 18079 A ID18079 A ID 18079A ID P972959 A IDP972959 A ID P972959A ID 972959 A ID972959 A ID 972959A ID 18079 A ID18079 A ID 18079A
Authority
ID
Indonesia
Prior art keywords
pharmaceutical composition
osteogenesis
fastest
osteoporosis
derivative
Prior art date
Application number
IDP972959A
Other languages
English (en)
Indonesian (id)
Inventor
Tetsuo Hoshino
Kazuhiro Saito
Susumu Iwasa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ID18079A publication Critical patent/ID18079A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IDP972959A 1996-08-26 1997-08-25 Komposisi farmasi yang mengandung bahan pemercepat osteogenesis ID18079A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP22344396 1996-08-26
JP9040897 1997-04-09

Publications (1)

Publication Number Publication Date
ID18079A true ID18079A (id) 1998-02-26

Family

ID=26431895

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP972959A ID18079A (id) 1996-08-26 1997-08-25 Komposisi farmasi yang mengandung bahan pemercepat osteogenesis

Country Status (9)

Country Link
US (1) US6190695B1 (de)
EP (1) EP0949927B1 (de)
AT (1) ATE226078T1 (de)
AU (1) AU3868997A (de)
CA (1) CA2264131A1 (de)
DE (1) DE69716469T2 (de)
ES (1) ES2181017T3 (de)
ID (1) ID18079A (de)
WO (1) WO1998008517A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS4518A (is) * 1997-07-09 1999-01-10 Lyfjathroun Hf, The Icelandic Bio Pharmaceutical Group Nýtt lyfjaform fyrir bóluefni
EP1087774A2 (de) * 1998-06-15 2001-04-04 Takeda Chemical Industries, Ltd. Zubereitungen, die bestimmte schewefelhaltende heterozyklische verbindungen enthalten, zur behandlung von knorpelerkrankungen
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
AR020158A1 (es) * 1998-08-12 2002-04-10 Takeda Chemical Industries Ltd Mejorador del factor de induccion para la diferenciacion celular
WO2001010463A1 (en) * 1999-08-05 2001-02-15 Takeda Chemical Industries, Ltd. Pastes with the sustained release of osteogenesis promoter
WO2001097784A1 (en) * 2000-06-23 2001-12-27 Takeda Chemical Industries, Ltd. Process for producing phospholipid-containing drugs
WO2002056914A1 (en) * 2001-01-19 2002-07-25 Hironori Yamamoto Injections for endoscopy
US6855332B2 (en) * 2002-07-03 2005-02-15 Lyfjathroun Hf. Absorption promoting agent
US8158685B2 (en) * 2004-07-02 2012-04-17 Gregory Gene Steiner Method for bone growth
CA2882048C (en) 2006-02-03 2020-03-24 Opko Renal, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
CA2683514C (en) * 2007-04-25 2019-07-09 Proventiv Therapeutics, Llc Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
CA2684778C (en) * 2007-04-25 2017-09-05 Cytochroma Inc. Methods and compounds for vitamin d therapy
WO2009047644A2 (en) * 2007-04-25 2009-04-16 Cytochroma Inc. Method of treating vitamin d insufficiency and deficiency
ES2401205T3 (es) 2007-04-25 2013-04-17 Cytochroma Inc. Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
KR101685031B1 (ko) 2008-04-02 2016-12-09 사이토크로마 인코포레이티드 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트
CN103037902A (zh) 2010-03-29 2013-04-10 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EP4596045A3 (de) 2016-03-28 2025-10-15 EirGen Pharma Ltd. Verfahren zur behandlung von vitamin d

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906475A (en) * 1988-02-16 1990-03-06 Paco Pharmaceutical Services Estradiol transdermal delivery system
NZ231939A (en) 1988-12-28 1991-07-26 Takeda Chemical Industries Ltd Benzothiopyran derivatives and medicaments
ES2157887T3 (es) * 1990-05-30 2001-09-01 Takeda Chemical Industries Ltd Compuestos heterociclicos que contienen azufre.
WO1994023740A1 (en) * 1993-04-22 1994-10-27 Celtrix Pharmaceuticals, Inc. Conjugates of growth factor and bone resorption inhibitor
JP3319625B2 (ja) * 1993-05-12 2002-09-03 ホーユー株式会社 速崩壊性生薬製剤
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
AR003001A1 (es) * 1995-06-05 1998-05-27 Takeda Chemical Industries Ltd Composicion farmaceutica estimuladora de la osteogenesis.

Also Published As

Publication number Publication date
ES2181017T3 (es) 2003-02-16
US6190695B1 (en) 2001-02-20
EP0949927B1 (de) 2002-10-16
ATE226078T1 (de) 2002-11-15
WO1998008517A3 (en) 1998-05-07
AU3868997A (en) 1998-03-19
DE69716469T2 (de) 2003-02-20
DE69716469D1 (de) 2002-11-21
EP0949927A2 (de) 1999-10-20
CA2264131A1 (en) 1998-03-05
WO1998008517A2 (en) 1998-03-05

Similar Documents

Publication Publication Date Title
ES2181017T3 (es) Composicion farmaceutica que contiene una sustancia promotora de osteogenesis y un polietilenglicol.
SE9901272D0 (sv) New improved formulation
ATE136221T1 (de) Osteo-induktive pharmazeutische formulierungen
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
ATE382057T1 (de) Stabile formulierung von modifiziertem glp-1
GT199700009AA (es) Terapia combinada para la osteoporosis
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
MY118151A (en) Pharmaceutical formulations containing voriconazole.
CY1109212T1 (el) Φαρμακευτικες συνθεσεις για την θεραπεια του ασθμα
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
SE9704186D0 (sv) New composition of matter
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
TR200101103T2 (tr) CGMP PDE-İnhibitörü içeren kontrollu serbest bırakılan farmasötik formülasyonlar
ATE212846T1 (de) Bisphosphonat und anti-resorption agentien, enthaltende zusammensetzungen zur hemmung der knochenschwund
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
ATE395071T1 (de) Pharmazeutische zubereitungen zur angiogenese- therapie
AP1424A (en) 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens.
ATE218364T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
BR0212857A (pt) Formulações e uso destas
WO2001030333A3 (en) Tissue factor antagonists and methods of use thereof
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
SE9802937D0 (sv) Novel compounds